HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 20, No 12, December 2016 – Medical Imaging Technology       » Climate Change Could Hurt Coffee, Help Banana Production       » Partnerships and Innovation: Shaping the Future of Healthcare in Asia Pacific       » Chugai's Novel Antibody Technologies Put Singapore at the Centre of Fight Against Disease       » NUS Scientists Discover the "Switch" that Makes Breast Cancer Cells Aggressive      
BIOBOARD - INSIDE INDUSTRY
Yakult Honsha and JAXA collaborate on research of the effect by probiotics on human immune function and gut microbiota
Yakult Honsha and Japan Aerospace Exploration Agency (JAXA) have reached an agreement to start a joint research in the International Space Station (ISS).

This research hopes to contribute to the health care of astronauts and the development of life science in the coming space age by scientifically studying the effect by probiotics on human immune function and gut microbiota of astronauts, who stay in space for long periods. It is also aimed at making contributions to promote people's health in general by utilizing the knowledge thus gained in the joint research for development of probiotics research on the ground.

The key research items are detailed below.

  • Study of the effect by probiotics on human immune function and gut microbiota in a microgravity environment in a confined microgravity environment (space)

  • Assessing the on-board safety, operability of live bacteria (Lactobacillus casei strain Shirota) and acquisition of related technical knowledge
Astronauts work in space, which is an extreme working environment of microgravity inside a closed spacecraft, and they are known to experience deterioration of immune function as well asbone density and muscular atrophy. In order to ensure a successful manned space flight, it is necessary to maintain the mental and physical health of the astronauts to enable them to fully demonstrate their capability. As one of the measures to tackle such issues, JAXA has been examining utilization of functional space food incorporating probiotics among other ingredients. Space development organizations in other countries are also about to embark on similar research.

For these reasons, Yakult and JAXA reached an agreement to embark on the joint research on probiotics in humans in space ahead of other countries.

The joint research is aimed at scientific examination of the influence of continuous consumption on the immune function and gut microbiota of astronauts stationed at ISS for a long period. They are also aiming to expand its scope to study how the impact of probiotic changes in outer space. The joint research, which combines the expertise Yakult has acquired over the years in gut microbiota research with JAXA's space biomedical research-related knowledge and laboratory technique in space, aims to not only allow astronauts to demonstrate their capabilities to the full extent but also contribute to the advancement of space medicine, often termed as ultimate preventive medicine, which is also expected to be applied on the ground.

Click here for the complete issue.

NEWS CRUNCH  
news Accuron Technologies' MedTech Division Invests into AWAK Technologies
news Philips introduces PerformanceBridge suite of operational performance improvement software and services for radiology departments
news Give a Gift that Will Last a Lifetime this Holiday Season with Smile Train
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Lungs & Respiratory System
February:
Cancer Research, Treatment/Technology
March:
Traditional Chinese Medicines
April:
Eye Care/ Eye Health
May:
The Piece of Your Mind - Brain Health/Science
June:
Featuring Biotech Start-Ups/Companies
July:
Food Science & Technology
August:
Diabetics Technology
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy